Clinical characteristics and treatment outcomes of Mycobacterium kansasiilung disease in korea

Yonsei Medical Journal

Volumn 51, Issue 4, 2010, Pages 552-556

  Park, Hye Kyeong ^a   Koh, Won Jung ^a   Shim, Tae Sun ^b   Kwon, O Jung ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Mycobacterium kansasii; Nontuberculous mycobacteria; Treatment outcome

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; LUNG CAVITATION; LUNG DISEASE; LUNG TUBERCULOSIS; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM KANSASII; OUTCOME ASSESSMENT; PROGNOSIS; SMOKING; SOUTH KOREA; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT OUTCOME; ATYPICAL MYCOBACTERIOSIS; COMPUTER ASSISTED TOMOGRAPHY; MIDDLE AGED; RADIOGRAPHY; RETROSPECTIVE STUDY;

AGED; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM KANSASII; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 77956193682     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2010.51.4.552     Document Type: Article

References (30)

1. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367-416.
2. Tsukamura M, Kita N, Shimoide H, Arakawa H, Kuze A. Studies on the epidemiology of nontuberculous mycobacteriosis in Japan. Am Rev Respir Dis 1988;137:1280-4.
3. Evans AJ, Crisp AJ, Hubbard RB, Colville A, Evans SA, Johnston ID. Pulmonary Mycobacterium kansasii infection: comparison of radiological appearances with pulmonary tuberculosis. Thorax 1996;51:1243-7.
4. Marras TK, Daley CL. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med 2002;23:553-67.
5. Falkinham JO 3rd. Nontuberculous mycobacteria in the environment. Clin Chest Med 2002;23:529-51.
6. Ahn CH, McLarty JW, Ahn SS, Ahn SI, Hurst GA. Diagnostic criteria for pulmonary disease caused by Mycobacterium kansasii and Mycobacterium intracellulare. Am Rev Respir Dis 1982;125: 388-91.
7. Johanson WG Jr, Nicholson DP. Pulmonary disease due to Mycobacterium kansasii. An analysis of some factors affecting prognosis. Am Rev Respir Dis 1969;99:73-85.
8. Christensen EE, Dietz GW, Ahn CH, Chapman JS, Murry RC, Hurst GA. Radiographic manifestations of pulmonary Mycobacterium kansasii infections. AJR Am J Roentgenol 1978;131: 985-93.
9. Shitrit D, Baum GL, Priess R, Lavy A, Shitrit AB, Raz M, et al. Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome. Chest 2006;129:771-6.
10. Griffith DE, Brown-Elliott BA, Wallace RJ Jr. Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study. Clin Infect Dis 2003;37:1178-82.
11. Shitrit D, Priess R, Peled N, Bishara G, Shlomi D, Kramer MR. Differentiation of Mycobacterium kansasii infection from Mycobacterium tuberculosis infection: comparison of clinical features, radiological appearance, and outcome. Eur J Clin Microbiol Infect Dis 2007;26:679-84.
12. Koh WJ, Kwon OJ, Lee KS. Diagnosis and treatment of nontuberculous mycobacterial pulmonary diseases: a Korean perspective. J Korean Med Sci 2005;20:913-25.
13. Lee JY, Choi HJ, Lee HY, Joung EY, Huh JW, Oh YM, et al. Recovery rate and characteristics of nontuberculous mycobacterial isolates in a university hospital in Korea. Tuberc Respir Dis 2005;58:385-91.
14. Koh WJ, Kwon OJ, Jeon K, Kim TS, Lee KS, Park YK, et al. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest 2006;129:341-8.
15. Ryoo SW, Shin S, Shim MS, Park YS, Lew WJ, Park SN, et al. Spread of nontuberculous mycobacteria from 1993 to 2006 in Koreans. J Clin Lab Anal 2008;22:415-20.
16. Koh WJ, Kwon OJ, Suh GY, Chung MP, Kim H, Lee NY, et al. A case report of three patients with nontuberculous mycobacterial pulmonary disease caused by Mycobacterium kansasii. Tuberc Respir Dis 2003;54:459-66.
17. Yim JJ, Park YK, Lew WJ, Bai GH, Han SK, Shim YS. Mycobacterium kansasii pulmonary diseases in Korea. J Korean Med Sci 2005;20:957-60.
18. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000;161:1376-95.
19. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008;246:697-722.
20. Koh WJ, Yu CM, Suh GY, Chung MP, Kim H, Kwon OJ, et al. Pulmonary TB and NTM lung disease: comparison of characteristics in patients with AFB smear-positive sputum. Int J Tuberc Lung Dis 2006;10:1001-7.
21. Kobashi Y, Matsushima T, Oka M. A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease. Respir Med 2007;101:130-8.
22. Anderson DH, Grech P, Townshend RH, Jephcott AE. Pulmonary lesions due to opportunist mycobacteria. (Review includes 30 cases of M. kansasii infections). Clin Radiol 1975;26:461-9.
23. Banks J, Hunter AM, Campbell IA, Jenkins PA, Smith AP. Pulmonary infection with Mycobacterium kansasii in Wales, 1970-9: review of treatment and response. Thorax 1983;38:271-4.
24. Christensen EE, Dietz GW, Ahn CH, Chapman JS, Murry RC, Anderson J, et al. Initial roentgenographic manifestations of pulmonary Mycobacterium tuberculosis, M kansasii, and M intracellularis infections. Chest 1981;80:132-6.
25. Ahn CH, Lowell JR, Onstad GD, Shuford EH, Hurst GA. A demographic study of disease due to Mycobacterium kansasii or M intracellulare-avium in Texas. Chest 1979;75:120-5.
26. Igari H, Kikuchi N. Nontuberculous Mycobacterium pulmonary infection with pleural effusion caused by Mycobacterium kansasii. Kekkaku 1993;68:527-31.
27. Kamiya H, Toyota E, Kobayashi N, Kudo K. A case of pulmonary Mycobacterium kansasii infection complicated with pleural effusion. Kekkaku 2004;79:397-400.
28. Olafsson EJ, Naum CC, Sarosi GA, Mastronarde JG. Bilateral pleural effusions and right pneumothorax in a 25-year-old man. Chest 2004;126:986-92.
29. Sauret J, Hernández-Flix S, Castro E, Hernández L, Ausina V, Coll P. Treatment of pulmonary disease caused by Mycobacterium kansasii: results of 18 vs 12 months' chemotherapy. Tuber Lung Dis 1995;76:104-8.
30. Santin M, Dorca J, Alcaide F, Gonzalez L, Casas S, Lopez M, et al. Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease. Eur Respir J 2009;33:148-52.